| Bioactivity | Rovanersen sodium is an antisense oligonucleotide that specifically targets mutated mRNA copies of the huntington (HTT) gene without affecting healthy mRNA of HTT gene, thereby preventing the production of faulty Huntingtin protein. Rovanersen sodium can be used for huntington’s disease research[1]. |
| CAS | 2231347-41-2 |
| Formula | C202H240N82Na19O111P19S13 |
| Molar Mass | 7034.70 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. M Meena, et al. Selectivity and Biodistribution of WVE-120101, a Potential Antisense Oligonucleotide Therapy for the Treatment of Huntington’s Disease (S56.001). AAN Enterprises. April 18, 2017; 88 (16 Supplement). |
Rovanersen sodium
CAS: 2231347-41-2 F: C202H240N82Na19O111P19S13 W: 7034.70
Rovanersen sodium is an antisense oligonucleotide that specifically targets mutated mRNA copies of the huntington (HTT)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.